Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Bill Haddad

1664 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • General

WeTrade Group Inc. Says ‘WeTrade and Zhixun are ready to launch an in-depth cooperative sales promotion of Zhixun’s disinfectant ‘

By Bill Haddad
August 18, 8:25 AM
BEIJING, Aug. 18, 2022 /PRNewswire/ -- WeTrade Group Inc. ("WeTrade" or the "Company") (NASDAQ:WETG), an emerging growth company engaged in the business of providing software-as-a-services

WETG

Read More
1 minute read
  • Buybacks
  • News

Plexus On August 17 Approved New Share Repurchase Program That Authorizes To Repurchase Up To $50.0M Of Common Stock

By Bill Haddad
August 18, 8:23 AM
-Reuters

PLXS

Read More
1 minute read
  • M&A

Dorman Products To Acquire SuperATV For $490M In Cash At Closing Plus Two-Year Earn-Out Of Up To $100M

By Bill Haddad
August 18, 8:09 AM
Dorman Products to acquire SuperATV for $490 million in cash at closing, plus a two-year earn-out of up to $100 million in the aggregate based on achievement of 2023 and 2024 performance targets.

DORM

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News

Jazz Pharmaceuticals Announces Initiation Of Phase 3 Trial Evaluating Epidiolex/Epidyolex For Patients With Epilepsy With Myoclonic-Atonic Seizures

By Bill Haddad
August 18, 7:32 AM
Trial is the first randomized, controlled clinical trial evaluating cannabidiol to treat children and adolescents living with a developmental and epileptic encephalopathy known as Epilepsy with

JAZZ

Read More
1 minute read
  • Legal
  • News

Perrigo Issues Statement In Response To Commentary On Zantac Litigation

By Bill Haddad
August 17, 4:25 PM
 In response to speculative commentary regarding ranitidine (Zantac®) litigation from a news story that contained certain misleading and inaccurate information, Perrigo Company plc (NYSE:PRGO), a leading

PRGO

Read More
1 minute read
  • Earnings
  • News

Bath & Body Works Q2 EPS $0.52 Beats $0.45 Estimate, Sales $1.62B Beat $1.58B Estimate

By Bill Haddad
August 17, 4:16 PM
Bath & Body Works (NYSE:BBWI) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.45 by 15.56 percent. This is a 61.19 percent decrease over earnings of $1.34 per share from the

BBWI

Read More
1 minute read
  • Earnings
  • News

Amcor Q4 EPS $0.07, Sales $3.91B Beat $3.77B Estimate

By Bill Haddad
August 17, 4:11 PM
Amcor (NYSE:AMCR) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.24 by 69.58 percent. This is a 68.26 percent decrease over earnings of $0.23 per share from the same

AMCR

Read More
1 minute read
  • Federal Reserve

Fed’s Bowman Says Labor Market Continues To Be Strong, Says Future Of Labor Supply Is Uncertain

By Bill Haddad
August 17, 2:23 PM
-Reuters

SPY

Read More
2 minute read
  • Legal
  • News

Partner Communications On August 17, Received A Lawsuit Filed By Lapidot Capital Ltd In Central District Court In Lod

By Bill Haddad
August 17, 2:14 PM
Partner Communications Company Ltd. ("Partner" or "the Company") (NASDAQ:PTNR) (TASE: PTNR), a leading Israeli communications operator, reports that on August 17, 2022, the Company

PTNR

Read More
3 minute read
  • Biotech
  • FDA
  • General
  • News

Bluebird Bio PR Announces FDA Approval Of ZYNTEGLO

By Bill Haddad
August 17, 2:07 PM
ZYNTEGLO offers potentially curative benefit across ages and genotypes, through the achievement of durable transfusion independence and normal or near normal total hemoglobin levels Management team to host conference

BLUE

Posts pagination

Previous 1 … 99 100 101 … 167 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service